CARDIOCEL— 510(k) K130872

Substantially Equivalent

Celxcel Pty, Ltd.

FDA 510(k) clearance K130872 for CARDIOCEL, Substantially Equivalent on 2014-01-30. Applicant: Celxcel Pty, Ltd..

Clearance details

Applicant: Celxcel Pty, Ltd.
Product code: Code DXZ
Advisory panel: Cardiovascular
Date received: 2013-03-29
Decision date: 2014-01-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rockville, MD, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DXZ

product code DXZ

Death: 19
Injury: 265
Total: 284

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.